The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer

Molecular Cancer Therapeutics

Volumn 3, Issue 4, 2004, Pages 451-457

  Rojanala, Sangeeta ^a,b   Han, Haiyong ^a,b   Muñoz, Rubén M ^a   Browne, Walden ^a   Nagle, Raymond ^a,c   Von Hoff, Daniel D ^a   Bearss, David J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA ACTIN; CASPASE 3; GENOMIC DNA; PROTEIN AURORA 2; PROTEIN SERINE THREONINE KINASE; RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; GENE AMPLIFICATION; GENE DUPLICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOSIS; PANCREAS CANCER; PRIORITY JOURNAL; SAMPLING;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; G2 PHASE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDES, ANTISENSE; PANCREATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES;

EID: 4444239881     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin, 2003;53:5-26.
2. Burris HI, Moore M, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 1997;15: 2403-13.
3. Han HY, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res, 2002;62:2890-6.
4. Giet R, Prigent C. Aurora/Ipl1 p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. J Cell Sci, 1999;112:3591-601.
5. Chan CS, Botstein D. Isolation and characterization of chromosome-gain and increase-in-ploidy mutants in yeast. Genetics, 1993;135: 677-91.
6. Schumacher JM, Ashcroft N, Donovan PJ, Golden A. A highly conserved centrosomal kinase, AIR-1, is required for accurate cell cycle progression and segregation of developmental factors in Caenorhabditis elegans embryos. Development, 1998;125:4391-402.
7. Glover DM, Leibowitz MH, McLean DA, Parry H. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell, 1995;81:95-105.
8. Bischoff JR, Plowman GD. The Aurora/Ipl1p kinase family: Regulators of chromosome segregation and cytokinesis. Trends Cell Biol, 1999;9: 454-9.
9. Bischoff JR, Anderson L, Zhu Y, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J, 1998;17:3052-65.
10. Sen S, Zhou H, White RA. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene, 1997;14:2195-200.
11. Zhou H, Kuang J, Zhong L, et al. Tumor amplified kinase STK15/BTAK induces centrosome amplification, aneuploidly and transformation [see comments]. Nat Genet, 1998;20:189-93.
12. Sakakura C, Hagiwara A, Yasuoka R, et al. Tumor-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer, 2001;84:824-31.
13. Kimura M, Kotani S, Hattori T, et al. Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1. J Biol Chem, 1997;272: 13766-71.
14. Gopalan G, Chan CS, Donovan PJ. A novel mammalian, mitotic spindle-associated kinase is related to yeast and fly chromosome segregation regulators. J Cell Biol, 1997;138:643-56.
15. Doxsey S. The centrosome - a tiny organelle with big potential [letter; comment]. Nat Genet, 1998;20:104-6.
16. Sato N, Mizumoto K, Nakamura M, et al. Centrosome abnormalities in pancreatic ductal carcinoma. Clin Cancer Res, 1999;5:963-70.
17. Pihan GA, Purohit A, Wallace J, et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res, 1998;58:3974-85.
18. Tanner MM, Grenman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res, 2000; 6:1833-9.
19. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res, 2002;62:2890-6.
20. Slamon DJ, Clark GM. Amplification of c-erbB-2 and aggressive human breast tumors? Science, 1988;240:1795-8.
21. McNeil C. Herceptin raises its sights beyond advanced breast cancer. J Natl Cancer Inst, 1998;90:882-3.
22. Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 1998;58: 2825-31.
23. Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H, Okano Y. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res, 1999;59:2041-4.
24. Sen S, Zhou H, Zhang RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst, 2002; 94:1320-9.
25. Gritsko TM, Coppola D, Paciga JE, et al. Activation and over-expression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res, 2003;9:1420-6.